heart failure Clinical Trials and Research
Also known as: congestive heart failure, chf, cardiac insufficiency, pump failure, hf · ICD-10: I50
Heart failure is a chronic condition where the heart muscle cannot pump enough blood to meet the body's needs. Clinical trial research is actively exploring new medications, devices, and lifestyle interventions to improve heart function and quality of life. Find a Trial helps patients search for active studies.
Common questions about heart failure clinical trials
Who can participate in heart failure clinical trials?
Eligibility criteria vary by study, often including factors like age, specific heart failure type, and overall health status. Researchers use these criteria to ensure patient safety and gather relevant data. Information on specific criteria can be found on ClinicalTrials.gov.
What are the different phases of heart failure clinical trials?
Clinical trials typically progress through phases, starting with small safety studies (Phase 1) and moving to larger studies evaluating effectiveness and side effects (Phases 2 and 3). Phase 4 studies monitor approved treatments. Each phase helps gather crucial data.
Do heart failure clinical trials cost money to participate in?
Generally, study-related medical care and interventions in clinical trials are provided at no cost to participants. However, some trials may not cover travel or other personal expenses. Patients should always clarify financial details with the research team.
What new treatments are being studied for heart failure?
Researchers are investigating novel medications, advanced medical devices like ventricular assist devices, and regenerative therapies to improve heart function. Studies also explore personalized approaches and better management strategies for symptoms. Data from NIH RePORTER and ClinicalTrials.gov show ongoing innovation.
What types of interventions are common in heart failure clinical trials?
Common interventions include new drug therapies aimed at improving heart pumping ability or reducing fluid retention. Device-based therapies, such as pacemakers or defibrillators, and lifestyle interventions like exercise programs are also frequently studied. These aim to manage symptoms and improve outcomes.
Are there specific biomarkers important in heart failure clinical trials?
Yes, biomarkers like B-type natriuretic peptide (BNP) or N-terminal pro-BNP (NT-proBNP) are often used to diagnose, assess severity, and monitor treatment response in heart failure studies. Researchers also explore new biomarkers for earlier detection and personalized care, as seen on ClinicalTrials.gov.
What might prevent someone from joining a heart failure clinical trial?
Common exclusion criteria can include severe kidney or liver disease, recent heart attack or stroke, or other uncontrolled medical conditions. Researchers set these to ensure patient safety and the integrity of study results. Each trial has specific criteria listed on ClinicalTrials.gov.
What are the potential benefits and risks of participating in a heart failure trial?
Potential benefits include access to new treatments before they are widely available and close medical monitoring. Risks can include unexpected side effects from new interventions or the treatment not being effective. Participants should discuss these thoroughly with the study team.
How to find a heart failure trial that fits you
- Describe your heart failure situation in detail — stage if applicable, prior treatments, age, and other relevant conditions.
- Use the location filter (worldwide, US, US & Canada, Europe) to narrow to trials near you.
- Review each trial's eligibility criteria carefully. Save 2–5 candidates with their NCT numbers.
- Discuss with your treating clinician before contacting the research site.
Browse all heart failure trials →